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Summary
Colorectal cancer (CRC) is the third most common cancer in men worldwide (746,000; 10%) 
and second most common in women (614,000 cases; 9.2%). Incidence and mortality are on the 
rise in many developing countries, closing the gap to the western, industrialized populations. 
In Croatia it is the second malignant cause of death in both males and females, while it ranks 
second in female incidence and third in male incidence. Trends in CRC in Croatia still display 
an increase in the standardized rates of incidence and mortality, however, the data for five-year 
survival for Croatia from recently published international studies indicate an improvement. The 
epidemiological data clearly point to CRC as one of the most important health issues of Croatian 
society. Its increasing incidence and mortality trends need to be tackled with a multidisciplinary 
approach, ensuring the availability of new treatment options and drugs when necessary, but 
also insisting on the secondary prevention (population-based screening) and primary prevention 
(changes in nutritional habits and levels of physical activity with educational activities targeted 
towards wider audience).
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The International Agency for Research on Cancer (IARC) estimates that over 14 
million people throughout the world develop cancer every year, while 8,2 million 
die of cancer annually; that number will increase to 19,3 million incident cases and 
11,4 million deaths by year 2025 [1]. Colorectal cancer (CRC) is an important health 
burden throughout the world; according to GLOBOCAN 2012 [2] 1.36 million new 
cases of CRC in the world occur each year, 447,000 of which in Europe. It makes it 
the third most common cancer in men worldwide (746,000; 10%) and second most 
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common in women (614,000 cases; 9.2%). The highest incidence rates of CRC are 
attributable to Australia and New Zealand; the highest mortality rates are observed 
in Central and Eastern Europe. The incidence of CRC is increasing in many develo-
ping countries with rates in the countries of Eastern Europe that recently underwent 
a major economic transition already reaching or exceeding those of the industrial 
western countries [3]. Reports from Eastern Asian countries also indicate a rapid 
rise in CRC incidence, closing the gap to Western populations [4,5].
The most recent data for Croatia (incidence for 2012 (6); mortality for 2013 [7]) in-
dicate that, in males, colorectal cancer is ranked third in incidence (1.700 new cases; 
crude incidence rate 82.8/100,000) and second in cancer causes of death (1.182 deaths; 
crude mortality rate 57.6/100,000). In females, colorectal cancer is ranked second in 
incidence (1.261 new cases; crude incidence rate 57.3/100.000) and second in cancer 
related mortality (855 deaths; crude mortality rate 38.8/100,000). The distribution 
of stages for CRC registered in the Croatian Cancer Registry in 2012 indicates that 
it was diagnosed at the localised stage in 20% of cases, with regional spreading or 
regional metastases in 38% of the cases, in 25% there were distant metastases at time 
of diagnosis, while for 17% of the cases the information on stage at diagnosis was 
missing.
According to the GLOBOCAN 2012 estimates [2], in males in Europe, Croatia 
is ranked 8th in incidence (age-standardized rate (ASR(W)) 44.2/100,000) and 3rd in 
mortality (ASR(W) 26.7/100,000); higher mortality rates are observed only in Hun-
gary and Slovakia. For women, Croatia is ranked 16th in incidence (24.7/100,000) and 
2nd in mortality (ASR(W) 13.0/100,000), with only Hungary having higher mortality 
rates. The estimated 5-year prevalence is 293.3/100,000 in males and 204.8/100,000 
in females [1]. Also, the cumulative risk (age 0-74) of incident colorectal cancer for 
Croatia was 5.25% in males and 2.86% for females, as shown in figures 1 and 2. The 
discrepancy between the incidence and mortality rank of Croatia in Europe stron-
gly indicates the need for improvement of prevention and treatment.
As for epidemiological situation in Croatia, a recent publication [8] described 
increasing trends in incidence and mortality of CRC in men in the period 1988-2008, 
with estimated annual percent changes (EAPC) of +2.9% for incidence and +2.1% for 
mortality. In women, the increase in incidence rates was not statistically significant, 
while mortality rates showed an increase for the period from 1994-2008, with EAPC 
of +1.1%. Given the high incidence and increasing mortality, Croatian Society of Co-
loproctology and Croatian Society of Oncology launched an incentive for quality 
control and referral improvements for colorectal cancer patients, recognizing the 
current lack of availability of some treatment modalities at different hospitals [9].
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Figure 1. Cumulative risk (0-74 years) of incident colorectal cancer in 
Europe, males. Source: GLOBOCAN 2012 (2)
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Figure 2. Cumulative risk (0-74 years) of incident colorectal cancer 
in Europe, females. Source: GLOBOCAN 2012 (2)
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The EUROCARE-5 study has provided data on cancer survival in European co-
untries, and for the first time in the EUROCARE history data from Croatia were 
included. The study indicated that the 5-year relative survival of Croatian cancer pa-
tients (diagnosed from 2000-2007 and followed-up until the end of 2008) was 49.6% 
for colon cancer, and 48.5% for rectal cancer (both sexes combined) [10]. This was 
lower than survival in western European countries (Austria 61.2%/61.1%), compara-
ble to similar European countries (Slovakia 51.4%/44.7%) and higher than survival 
in Eastern European countries such as Bulgaria (45.2%/38.4%).  
The recently published CONCORD-2 study evaluated cancer survival for over 
25 million cancer patients from 279 cancer registries in 67 countries [11]. The data for 
Croatia (19,846 eligible patients for colon cancer and 12,240 for rectal cancer) indicate 
that the net five-year survival has improved from 50.1% in the 1998-1999 period to 
52.0% in 2005-2009 period, while the improvement in rectal cancer was from 44.6% 
in the 1998-1999 period to 48.2% in the 2005-2009 period. 
Results of colorectal cancer screening in Croatia indicate that, in the first cycle, 
a total of 1.404.300 individuals were invited to screening.  In total, 288.935 (21%) 
persons returned the test packages with a correctly placed stool specimen on FOBT 
cards. Over 10,000 colonoscopies were performed and 576 colon cancers were dis-
covered [12].
In conclusion, the epidemiological data indicate that CRC is one of the most im-
portant health issues of Croatian society. Its rising incidence and mortality trends 
need to be tackled with a multidisciplinary approach, ensuring the availability of 
new treatment options and drugs, but also insisting on the secondary prevention 
(population-based screening) and primary prevention (changes in nutritional habits 
and levels of physical activity, as well as appropriate educational activities).
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Sažetak
Epidemiologija kolorektalnog raka u Hrvatskoj i svijetu
Kolorektalni karcinom diljem svijeta zauzima treće mjesto među najčešćim zloćudnim bo-
lestima  muškaraca (746.000; 10%)  i drugo mjesto učestalosti kod žena (614.000; 9,2%). U ze-
mljama u razvoju incidencija i mortalitet su u porastu, što pridonosi smanjenju raskoraka prema 
zapadnim, industrijaliziranim populacijama. U Hrvatskoj je kolorektalni karcinom drugi uzrok 
smrtnosti od zloćudnih bolesti i kod muškaraca i žena. Kod žena se po incidenciji svrstava na 
drugo mjesto, a kod muškaraca na treće. Trendovi kod kolorektalnog karcinoma u Hrvatskoj 
još uvijek imaju sklonost porasta u standardiziranim stopama incidencije i mortaliteta, međutim 
podaci o petogodišnjem preživljenju iz recentno objavljenih međunarodnih studija ukazuju na 
poboljšanja. Epidemiološki podaci jasno ukazuju kako je kolorektalni karcinom jedna od najvaž-
nijih javnozdravstvenih stavki u Hrvatskoj. Njegova rastuća incidencija i mortalitet upozoravaju 
na važnost uloge multidisciplinarnog pristupa, osiguranje dostupnosti novih modaliteta liječenja 
kada je potrebno, kao i inzistiranje na sekundarnoj prevenciji (probir na populacijskoj razini) i 
primarnoj prevenciji (promjene prehrambenih navika i razine tjelesne aktivnosti, uz edukaciju 
šire javnosti o problemu kolorektalnog karcinoma).
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